Assignee
MOLOGEN AG
DE9 patents
Top patents by PatentIndex Score
US10604760B2Mar 31, 2020
Combination comprising immunostimulatory oligonucleotides
MOLOGEN AG5 citations81
US10487333B2Nov 26, 2019
Combination comprising immunostimulatory oligonucleotides
MOLOGEN AG7 citations81
US7635468B2Dec 22, 2009
Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
MOLOGEN AG13 citations80
US8017591B2Sep 13, 2011
Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals
MOLOGEN AG13 citations77
US10006032B2Jun 26, 2018
Predictive biomarker for cancer therapy
MOLOGEN AG4 citations71
US7074772B2Jul 11, 2006
Design principle for the construction of expression constructs for gene therapy
MOLOGEN AG9 citations71
US10280424B2May 7, 2019
Covalently closed non-coding immunomodulatory DNA construct
MOLOGEN AG5 citations67
US7915035B2Mar 29, 2011
Vaccine against oncovirus infections such as infections by feline leukosis virus of the cat
MOLOGEN AG1 citations46
US7795406B2Sep 14, 2010
Agent for treating leishmania infections
MOLOGEN AG0 citations41